Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
225-238
Author(s):
J. Garcia de Yebenes and M. P. Sanchez
Neuroprotective Mechanisms as Treatment Strategy in Alzheimers disease
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
239-246
Author(s):
Agneta Nordberg
Elucidating Neuronal and Vascular Injury Through the Cytoprotective Agent Nicotinamide
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
257-267
Author(s):
Kenneth Maiese, Shi-Hua Lin and Zhao Zhong Chong
Current Aspects of Pathophysiology and Cell Dysfunction after Severe Head Injury
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1475-1503
Author(s):
J. Sahuqillo, M. A. Poca and S. Amoros
Pharmacologic Therapy In Traumatic Brain Injury: Update On Experimental Treatment Strategies
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1505-1516
Author(s):
H. L. Laurer and T. K. McIntosh
Therapeutic Moderate Hypothermia and Fever
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1533-1536
Author(s):
D. W. Marion
NMDA Receptor Pharmacology: Perspectives from Molecular Biology
Journal:
Current Drug Targets
Volume:
2
Page:
215-231
Author(s):
David R. Lynch and Rodney P. Guttmann
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
NMDA Receptors and Learning and Memory Processes
Journal:
Current Drug Targets
Volume:
2
Page:
273-283
Author(s):
C. Castellano, V. Cestari and A. Ciamei
Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action
Journal:
Current Drug Targets
Volume:
2
Page:
285-298
Author(s):
Keith Williams